Mahadeo Karnik Board of Director Membership

Home

Insights

Mahadeo Karnik Board Membership

Last Updated on: Nov 14, 2024

About Mahadeo Karnik

Mahadeo Karnik, who was appointed as an Additional Director on the Board of Abbott India Ltd effective July 1, 2023, has extensive experience in the finance sector, having previously worked with notable companies such as Perkin Elmer India Private Limited and Roche Diagnostics India Private Limited.
He is a fellow member of the Institute of Chartered Accountants of India and the Institute of Cost and Management Accountants of India.
Mahadeo is recognized for his expertise in financial analysis, capital markets, corporate taxation, and mergers and acquisitions.
He has played a key role in developing and implementing innovative business models and growth strategies, and has been instrumental in driving automation and digitization projects critical for the company.
His appointment was confirmed by the shareholders, and he is not disqualified from serving as a director under the Companies Act.

List of Companies Associated with Mahadeo Karnik

Company Name	Position Held	Market Cap	Sector	Date Of Appointment

Abbott India Ltd

Non Executive Director

61715.21

Pharmaceuticals

Mar, 2024

Company Name	Position Held
Abbott India Ltd	Non Executive Director

PRICE

<p>The current market price or CMP refers to the price of those companies associated with Mahadeo Karnik at which the securities are trading in the share market.</p> <br> <h2>Current price in Over-the-counter costs:</h2> <p>The following current price of those companies associated with Mahadeo Karnik depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC).</p> <br> <h2>Current Price in Bond Market: </h2> <p>The current price of a bond of those companies associated with Mahadeo Karnik is determined by measuring the actual interest rate against the bid-related interest rate.</p> <br> <p>The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.</p>

Historical Share prices

* All values are in Rupees

Mahadeo Karnik Sector Specific Experience

About Mahadeo Karnik's work experience

Mahadeo Karnik is currently a Non Executive Director in Abbott India Ltd (as of Mar 2024).
Mahadeo Karnik is serving the company - Abbott India Ltd at this position since 2024 for the last 1+ years.
Prior to becoming Non Executive Director, Mahadeo Karnik was Director of Abbott India Ltd for 1 year in 2023.

FAQ's related Mahadeo Karnik

Who is Mahadeo Karnik

Mahadeo Karnik, who was appointed as an Additional Director on the Board of Abbott India Ltd effective July 1, 2023, has extensive experience in the finance sector, having previously worked with notable companies such as Perkin Elmer India Private Limited and Roche Diagnostics India Private Limited. He is a fellow member of the Institute of Chartered Accountants of India and the Institute of Cost and Management Accountants of India. Mahadeo is recognized for his expertise in financial analysis, capital markets, corporate taxation, and mergers and acquisitions. He has played a key role in developing and implementing innovative business models and growth strategies, and has been instrumental in driving automation and digitization projects critical for the company. His appointment was confirmed by the shareholders, and he is not disqualified from serving as a director under the Companies Act.

Which companies does Mahadeo Karnik serve as a board member for?

Mahadeo Karnik serves as a board member for: Abbott India Ltd

What positions has Mahadeo Karnik held in his/her career?

Throughout their career, Mahadeo Karnik has held key positions such as Non Executive Director,Director, contributing to the growth and success of each company.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*